Literature DB >> 28408005

Balancing the Optimal and the Feasible: A Practical Guide for Setting Up Patient Registries for the Collection of Real-World Data for Health Care Decision Making Based on Dutch Experiences.

Saskia de Groot1, Naomi van der Linden2, Margreet G Franken3, Hedwig M Blommestein4, Brenda Leeneman2, Ellen van Rooijen2, J J M Koos van der Hoeven5, Michel W Wouters6, Hans M Westgeest7, Carin A Uyl-de Groot8.   

Abstract

OBJECTIVES: The aim of this article was to provide practical guidance in setting up patient registries to facilitate real-world data collection for health care decision making.
METHODS: This guidance was based on our experiences and involvement in setting up patient registries in oncology in the Netherlands. All aspects were structured according to 1) mission and goals ("the Why"), 2) stakeholders and funding ("the Who"), 3) type and content ("the What"), and 4) identification and recruitment of patients, data handling, and pharmacovigilance ("the How").
RESULTS: The mission of most patient registries is improving patient health by improving the quality of patient care; monitoring and evaluating patient care is often the primary goal ("the Why"). It is important to align the objectives of the registry and agree on a clear and functional governance structure with all stakeholders ("the Who"). There is often a trade off between reliability, validity, and specificity of data elements and feasibility of data collection ("the What"). Patient privacy should be carefully protected, and address (inter-)national and local regulations. Patient registries can reveal unique safety information, but it can be challenging to comply with pharmacovigilance guidelines ("the How").
CONCLUSIONS: It is crucial to set up an efficient patient registry that serves its aims by collecting the right data of the right patient in the right way. It can be expected that patient registries will become the new standard alongside randomized controlled trials due to their unique value.
Copyright © 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  decision making; observational studies; real-world data; registries

Mesh:

Year:  2016        PMID: 28408005     DOI: 10.1016/j.jval.2016.02.007

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  12 in total

1.  Registries for study of nonmalignant hematological diseases: the example of the Severe Chronic Neutropenia International Registry.

Authors:  David C Dale; Audrey Anna Bolyard; Laurie A Steele; Cornelia Zeidler; Karl Welte
Journal:  Curr Opin Hematol       Date:  2020-01       Impact factor: 3.284

Review 2.  Systematic review of model-based economic evaluations of heart valve implantations.

Authors:  Simone A Huygens; Johanna J M Takkenberg; Maureen P M H Rutten-van Mölken
Journal:  Eur J Health Econ       Date:  2017-03-06

3.  An Inventory of European Birth Cohorts.

Authors:  Claudia Pansieri; Chiara Pandolfini; Antonio Clavenna; Imti Choonara; Maurizio Bonati
Journal:  Int J Environ Res Public Health       Date:  2020-04-28       Impact factor: 3.390

4.  Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in the PSOLAR registry.

Authors:  Arthur Kavanaugh; Kim Papp; Alice B Gottlieb; Elke M G J de Jong; Soumya D Chakravarty; Shelly Kafka; Wayne Langholff; Kamyar Farahi; Bhaskar Srivastava; Jose U Scher
Journal:  BMC Rheumatol       Date:  2018-09-29

5.  Developing a Preliminary Conceptual Framework for Guidelines on Inclusion of Patient Reported-Outcome Measures (PROMs) in Clinical Quality Registries.

Authors:  Rasa Ruseckaite; Ashika D Maharaj; Karolina Krysinska; Joanne Dean; Susannah Ahern
Journal:  Patient Relat Outcome Meas       Date:  2019-12-10

6.  Controversies in Choledochal Malformation in Children: An International Survey among Pediatric Hepatobiliary Surgeons and Gastroenterologists.

Authors:  Jan B F Hulscher; Joachim F Kuebler; Janneke M Bruggink; Mark Davenport; Stefan Scholz; Claus Petersen; Omid Madadi-Sanjani; Nagoud Schukfeh
Journal:  J Clin Med       Date:  2022-02-21       Impact factor: 4.241

7.  Preliminary development of recommendations for the inclusion of patient-reported outcome measures in clinical quality registries.

Authors:  Rasa Ruseckaite; Ashika D Maharaj; Joanne Dean; Karolina Krysinska; Ilana N Ackerman; Angela L Brennan; Ljoudmila Busija; Helen Carter; Arul Earnest; Christopher B Forrest; Ian A Harris; Janet Sansoni; Susannah Ahern
Journal:  BMC Health Serv Res       Date:  2022-03-01       Impact factor: 2.655

8.  Establishing a Sickle Cell Disease Registry in Africa: Experience From the Sickle Pan-African Research Consortium, Kumasi-Ghana.

Authors:  Vivian Paintsil; Evans Xorse Amuzu; Isaac Nyanor; Emmanuel Asafo-Adjei; Abdul Razak Mohammed; Suraj Abubakar Yawnumah; Yaa Gyamfua Oppong-Mensah; Samuel Blay Nguah; Paul Obeng; Elliot Eli Dogbe; Mario Jonas; Victoria Nembaware; Gaston Mazandu; Kwaku Ohene-Frempong; Ambroise Wonkam; Julie Makani; Daniel Ansong; Alex Osei-Akoto
Journal:  Front Genet       Date:  2022-02-24       Impact factor: 4.599

9.  Recommendations for Improving the Quality of Rare Disease Registries.

Authors:  Yllka Kodra; Jérôme Weinbach; Manuel Posada-de-la-Paz; Alessio Coi; S Lydie Lemonnier; David van Enckevort; Marco Roos; Annika Jacobsen; Ronald Cornet; S Faisal Ahmed; Virginie Bros-Facer; Veronica Popa; Marieke Van Meel; Daniel Renault; Rainald von Gizycki; Michele Santoro; Paul Landais; Paola Torreri; Claudio Carta; Deborah Mascalzoni; Sabina Gainotti; Estrella Lopez; Anna Ambrosini; Heimo Müller; Robert Reis; Fabrizio Bianchi; Yaffa R Rubinstein; Hanns Lochmüller; Domenica Taruscio
Journal:  Int J Environ Res Public Health       Date:  2018-08-03       Impact factor: 3.390

10.  The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage.

Authors:  Anna Ambrosini; Daniela Calabrese; Francesco Maria Avato; Felice Catania; Guido Cavaletti; Maria Carmela Pera; Antonio Toscano; Giuseppe Vita; Lucia Monaco; Davide Pareyson
Journal:  Orphanet J Rare Dis       Date:  2018-10-04       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.